< Back to companies

Neurogen Biomarking is dedicated to supporting early detection of Alzheimer’s disease and Mild Cognitive Impairment. Founded by award-winning neurologist, Dr. Rany Aburashed and guided by world-renowned brain health experts, Neurogen is on a mission to empower anyone with thinking and memory concerns with the tools, education, and motivation needed to access advanced, personalized care of patients with Alzheimer's disease – and a future with more in it.

Only accessible to MedStartr community members. Join now

Company Info

Founded
2024
Website
neurogenbiomarking.com/

Categories

Alzheimer(s) DiseaseBiomarker MonitoringDiagnostics & MonitoringScreening & Early Detection

Disease Areas

Technologies

BiomarkersDiagnostic TestingScreening Technology
Only accessible to MedStartr community members. Join now

What do you think of Neurogen Biomarking?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Innovation

Clinical Benefit

Feasibility

Scalability

Only accessible to MedStartr community members. Join now